Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | DRD3 | P35462 | 2/20 | 0.39 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.39 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.39 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.35 |
| ▸ | APP | P05067 | 4/20 | 0.35 |
| ▸ | SNCA | P37840 | 4/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | NR2E1 | Q9Y466 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 7/20 | 0.33 |
| ▸ | RXRA | P19793 | 5/20 | 0.33 |
| ▸ | RARA | P10276 | 5/20 | 0.33 |
| ▸ | RARB | P10826 | 5/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19019764 | 0.89 | CYP1A2 (0.37) | CYP1A2ALDH1A1PTGS1LMNADRD3 | |
| SCHEMBL19019762 | 0.89 | CYP1A2 (0.37) | CYP1A2ALDH1A1PTGS1LMNADRD3 | |
| SCHEMBL21523570 | 0.81 | — | — | |
| SCHEMBL19167425 | 0.76 | CYP1A2 (0.40) | CYP1A2ALDH1A1PTGS1LMNADRD3 | |
| SCHEMBL2135859 | 0.76 | CYP1A2 (0.36) | CYP1A2ALDH1A1PTGS1LMNADRD3 | |
| SCHEMBL29063474 | 0.76 | KRAS (0.34) | CYP1A2 | |
| SCHEMBL1242169 | 0.76 | CYP1A2 (0.36) | CYP1A2ALDH1A1PTGS1LMNADRD3 | |
| SCHEMBL4678663 | 0.76 | CYP1A2 (0.40) | CYP1A2ALDH1A1PTGS1LMNADRD3 | |
| SCHEMBL1659293 | 0.76 | CYP1A2 (0.44) | CYP1A2ALDH1A1PTGS1LMNADRD3 | |
| SCHEMBL9342959 | 0.74 | CYP1A2 (0.51) | CYP1A2ALDH1A1PTGS1LMNADRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020086895-A1 | Methods of treating fungal infections | CHU WAI-LAM ALEX (US) | 2002-07-04 | — | — | US | claimed |
| EP-1005338-A4 | SUBSTITUTED AURONE DERIVATIVES | PHYTERA INC (US) | 2001-11-07 | — | — | EP | claimed |
| US-6111125-A | Preparation of (1R,4S)-4-hydroxy-1,2,2-trimethylcyclopentyl methyl ketone and derivatives and stereoisomers of this compound | BASF AKTIENGESELLSCHAFT (DE) | 2000-08-29 | — | — | US | claimed |
| EP-1005338-A1 | SUBSTITUTED AURONE DERIVATIVES | PHYTERA, INC. (US) | 2000-06-07 | — | — | EP | claimed |
| WO-1999004789-A1 | SUBSTITUTED AURONE DERIVATIVES | PHYTERA, INC. (US) | 1999-02-04 | — | — | WO | claimed |
| EP-0673378-B1 | NEW TRIAZOLOPYRIMIDONES, THEIR PREPARATION AND THEIR USE | BASF AG (DE) | 1997-03-12 | — | — | EP | claimed |
| EP-0671378-B1 | Process for the preparation of (1R,4S)-4-hydroxy-1,2,2-trimethylcyclopentyl-methylketone, its derivatives and stereoisomers | BASF AG (DE) | 1997-01-29 | — | — | EP | claimed |
| US-4073813-A | PLATINUM REDUCTION CATALYST, ALDEHYDES, HYDROGEN | RHONE-POULENC INDUSTRIES (FR) | 1978-02-14 | — | — | US | claimed |
| EP-3184172-B1 | HYDROSILYLATION IRON CATALYST | UNIV KYUSHU NAT UNIV CORP (JP) | 2024-09-04 | — | — | EP | disclosed |
| US-12016963-B2 | Freshening compositions with alkoxylated phenols | THE PROCTER & GAMBLE COMPANY (US) | 2024-06-25 | — | — | US | disclosed |
| US-11946018-B2 | Freshening compositions with ethoxylated/propoxylated aromatics | THE PROCTER & GAMBLE COMPANY (US) | 2024-04-02 | — | — | US | disclosed |
| CN-113861343-B | Urethane (meth) acrylate, active energy ray-curable resin composition, cured product, and laminate | 荒川化学工业株式会社 | 2023-11-10 | — | — | CN | disclosed |
| CN-113861343-A | Urethane (meth) acrylate, active energy ray-curable resin composition, cured product, and laminate | 荒川化学工业株式会社 | 2021-12-31 | — | — | CN | disclosed |
| CN-106573235-B | Iron hydrosilylate catalyst | 国立大学法人九州大学 | 2020-07-07 | — | — | CN | disclosed |
| US-4404301-A | Polymeric light stabilizers having at least one 2,2,6,6-tetraalkyl piperidyl group and synthetic resin compositions containing the same | ADEKA ARGUS CHEMICAL CO., LTD. (JP) | 1983-09-13 | — | — | US | disclosed |
| EP-0046606-A1 | Oxygenated alicyclic compounds, process for their preparation and their use as starting materials in the preparation of cyclohexadienic compounds | FIRMENICH SA (CH) | 1982-03-03 | — | — | EP | disclosed |
| US-4215230-A | Production of ionones and irones by thermal rearrangement of propargylic alcohols | KURARAY CO., LTD. (JP) | 1980-07-29 | — | — | US | disclosed |
| US-4179468-A | Cyclic terpenoid onium salts, their preparation and uses | SCM CORPORATION (US) | 1979-12-18 | — | — | US | disclosed |
| US-4105697-A | Process for the preparation of α, β-ethylenic aldehydes | RHONE-POULENC INDUSTRIES (FR) | 1978-08-08 | — | — | US | disclosed |
| US-4073813-A | PLATINUM REDUCTION CATALYST, ALDEHYDES, HYDROGEN | RHONE-POULENC INDUSTRIES (FR) | 1978-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020086895-A1 | Methods of treating fungal infections | COXFA4L2, DPM1, ERG28 | CYP1A2 909/4885ALDH1A1 1149/4885PTGS1 1873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.